In a case study meant to determine the risk factors directly connected to multidrug resistance characteristic for Proteus Mirabilis, 99 in patients suffering from bloodstream infections caused by Proteus Mirabilis were identified and studied over a period of 11 years (Tumbarello et al., 2012). The risk factors causing their ailments were determined by comparing the survivors and the numbers of those who died. Those admitted to long-term care facilities and placed under treatment for Proteus Mirabilis without much improvement were deemed to have acquired multidrug resistant strains. These were patients who had undergone previous fluoroquinolone therapy, long-term hospitalization, or oxyimino-cephalosporins therapy. Patients
In a case study meant to determine the risk factors directly connected to multidrug resistance characteristic for Proteus Mirabilis, 99 in patients suffering from bloodstream infections caused by Proteus Mirabilis were identified and studied over a period of 11 years (Tumbarello et al., 2012). The risk factors causing their ailments were determined by comparing the survivors and the numbers of those who died. Those admitted to long-term care facilities and placed under treatment for Proteus Mirabilis without much improvement were deemed to have acquired multidrug resistant strains. These were patients who had undergone previous fluoroquinolone therapy, long-term hospitalization, or oxyimino-cephalosporins therapy. Patients